A mitochondrial bioenergetic etiology of disease

Journal of Clinical Investigation

Volumn 123, Issue 4, 2013, Pages 1405-1412

  Wallace, Douglas C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; FORMYLMETHIONINE; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

ARTICLE; CALCIUM METABOLISM; COLD TOLERANCE; DNA POLYMORPHISM; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EPIGENETICS; EXTRACHROMOSOMAL INHERITANCE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL GENE; MITOCHONDRIAL GENETICS; MITOCHONDRIAL GENOME; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROMUSCULAR DISEASE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOMATIC MUTATION;

ANIMALS; DNA, MITOCHONDRIAL; ENERGY METABOLISM; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENOME, MITOCHONDRIAL; HUMAN MIGRATION; HUMANS; METABOLIC DISEASES; MUTATION; NEUROMUSCULAR DISEASES;

EID: 84875868055     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI61398     Document Type: Article

References (97)

1. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359-407.
2. Wallace DC. Why do we have a maternally inherited mitochondrial DNA? Insights from Evolutionary Medicine. Annu Rev Biochem. 2007;76:781-821.
3. Wallace DC, Lott MT, Procaccio V. Mitochondrial medicine: The mitochondrial biology and genetics of metabolic and degenerative diseases, cancer, and aging. In: Rimoin DL, Pyeritz RE, Korf BR, eds. Emery and Rimoin's Principles and Practice of Medical Genetics. Philadelphia, Pennsylvania, USA: Churchill Livingstone Elsevier; 2013.
4. Wallace DC, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242(4884):1427-1430.
5. Ruiz-Pesini E, et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res. 2007;35(database issue):D823-D828.
6. Sadun AA, La Morgia C, Carelli V. Leber's Hereditary Optic Neuropathy. Curr Treat Options Neurol. 2011;13(1):109-117.
7. Wallace DC, et al. Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell. 1988;55(4):601-610.
8. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell. 1990;61(6):931-937.
9. Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348(6302):651-653.
10. Wallace DC. Mitochondria as chi. Genetics. 2008;179(2):727-735.
11. Gomez-Duran A, et al. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet. 2010;19(17):3343-3353.
12. Fan W, et al. A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science. 2008;319(5865):958-962.
13. Stewart JB, Freyer C, Elson JL, Larsson NG. Purifying selection of mtDNA and its implications for understanding evolution and mitochondrial disease. Nat Rev Genet. 2008;9(9):657-662.
14. Wallace DC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci U S A. 1994;91(19):8739-8746.
15. Wallace DC, Brown MD, Lott MT. Mitochondrial DNA variation in human evolution and disease. Gene. 1999;238(1):211-230.
16. Kazuno AA, et al. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet. 2006;2(8):e128.
17. Shoffner JM, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics. 1993;17(1):171-184.
18. Brown MD, Torroni A, Reckord CL, Wallace DC. Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNA's indicates multiple independent occurrences of the common mutations. Hum Mutat. 1995;6(4):311-325.
19. Liang M, et al. Leber's hereditary optic neuropathy is associated with mitochondrial ND1 T3394C mutation. Biochem Biophys Res Commun. 2009;383(3):286-292.
20. Ji F, et al. Mitochondrial DNA variant associated with Leber hereditary optic neuropathy and high-altitude Tibetans. Proc Natl Acad Sci U S A. 2012;109(19):7391-7396.
21. Rollins B, et al. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One. 2009;4(3):e4913.
22. Khusnutdinova E, et al. A mitochondrial etiology of neurodegenerative diseases: Evidence from Parkinson's disease. Ann N Y Acad Sci. 2008;1147:1-20.
23. Fuku N, et al. Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am J Hum Genet. 2007;80(3):407-415.
24. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988; 331(6158):717-719.
25. Cortopassi G, Arnheim N. Accumulation of mitochondrial DNA mutation in normal aging brain and muscle. In: DiMauro S, Wallace DS, eds. Mitochondrial DNA in Human Pathology. New York, New York, USA: Raven Press; 1992:125-136.
26. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nat Genet. 1992;2(4):324-329.
27. Soong NW, Hinton DR, Cortopassi G, Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet. 1992;2(4):318-323.
28. Sequeira A, et al. Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet. 2012;3:103.
29. Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 1999;286(5440):774-779.
30. Murdock DG, Christacos NC, Wallace DC. The agerelated accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method. Nucleic Acids Res. 2000;28(21):4350-4355.
31. Trifunovic A, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429(6990):417-423.
32. Kujoth GC, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005;309(5733):481-484.
33. Schriner SE, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005;308(5730):1909-1911.
34. Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. JAMA. 1991;266(13):1812-1816.
35. Corral-Debrinski M, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics. 1994;23(2):471-476.
36. Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci U S A. 2004;101(29):10726-10731.
37. Coskun PE, et al. Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. J Alzheimers Dis. 2010;20(suppl 2):S293-S310.
38. Coskun P, et al. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta. 2011;1820(5):553-564.
39. Bender A, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006;38(5):515-517.
40. Horton TM, et al. Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's Disease patients. Neurology. 1995; 45(10):1879-1883.
41. Zhang Q, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104-107.
42. Krysko DV, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 2011;32(4):157-164.
43. Oka T, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012;485(7397):251-255.
44. Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. N Engl J Med. 2012;366(12):1132-1141.
45. Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet. 2001;28(3):211-212.
46. Spelbrink JN, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet. 2001;28(3):223-231.
47. Mandel H, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 2001;29(3):337-341.
48. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 2001;29(3):342-344.
49. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283(5402):689-692.
50. Kaukonen J, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science. 2000;289(5480):782-785.
51. Palmieri L, et al. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum Mol Genet. 2005; 14(20):3079-3088.
52. Potluri P, et al. A novel NDUFA1 mutation leads to a progressive mitochondrial complex I-specific neurodegenerative disease. Mol Genet Metab. 2009;96(4):189-195.
53. Wallace DC, Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion. 2010;10(1):12-31.
54. Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol. 2010;5:297-348.
55. Wallace DC. Bioenergetic origins of complexity and disease. Cold Spring Harb Symp Quant Biol. 2011;76:1-16.
56. Suen DF, Narendra DP, Tanaka A, Manfredi G, Youle RJ. Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc Natl Acad Sci U S A. 2010;107(26):11835-11840.
57. Chen H, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell. 2010;141(2):280-289.
58. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006;38(5):518-520.
59. Glabe CG, Kayed R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology. 2006; 66(2 suppl 1):S74-S78.
60. Crouch PJ, et al. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci. 2005; 25(3):672-679.
61. Schon EA, Area-Gomez E. Is Alzheimer's disease a disorder of mitochondria-associated membranes? J Alzheimers Dis. 2010;20(suppl 2):S281-S292.
62. Contreras L, Drago I, Zampese E, Pozzan T. Mitochondria: The calcium connection. Biochim Biophys Acta. 2010;1797(6-7):607-618.
63. Filipek PA. Medical aspects of autism. In: Volkmar FR, Klin A, Paul R, Cohen DJ, eds. Handbook of Autism and Pervasive Developmental Disorders. New York, New York, USA: John Wiley and Sons; 2005:534-578.
64. Gargus JJ, Imtiaz F. Mitochondrial energy-deficient endophenotype in autism. Am J Biochem Biotech. 2008;4(2):198-207.
65. Giulivi C, et al. Mitochondrial dysfunction in autism. JAMA. 2010;304(21):2389-2396.
66. Chauhan A, et al. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem. 2011;117(2):209-220.
67. Smith M, et al. Mitochondrial and ion channel gene alterations in autism. Biochim Biophys Acta. 2012;1817(10):1796-1802.
68. Palmieri L, et al. Altered calcium homeostasis in autism-spectrum disorders: Evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry. 2010;15(1):38-52.
69. McCormack JG, Denton RM. A comparative study of the regulation of Ca2+ of the activities of the 2-oxoglutarate dehydrogenase complex and NAD+-isocitrate dehydrogenase from a variety of sources. Biochem J. 1981;196(2):619-624.
70. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev. 1990;70(2):391-425.
71. Splawski I, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A. 2005;102(23):8089-8096.
72. Myers RA, et al. A population genetic approach to mapping neurological disorder genes using deep resequencing. PLoS Genet. 2011;7(2):e1001318.
73. Sebat J, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316(5823):445-449.
74. Zhao X, et al. A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci U S A. 2007;104(31):12831-12836.
75. Glessner JT, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459(7246):569-573.
76. Gai X, et al. Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry. 2012;17(4):402-411.
77. Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183(5):795-803.
78. Su H, et al. Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome. Neurosci Lett. 2011;487(2):129-133.
79. Daniels JL, et al. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics. 2008;121(5):e1357-e1362.
80. Talkowski ME, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell. 2012;149(3):525-537.
81. Gardner A, Boles RG. Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):730-743.
82. McMahon FJ, Stine OC, Meyers DA, Simpson SG, DePaulo Jr. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet. 1995;56(6):1277-1286.
83. Verge B, et al. New evidence for the involvement of mitochondrial inheritance in schizophrenia: Results from a cross-sectional study evaluating the risk of illness in relatives of schizophrenia patients. J Clin Psychiatry. 2012;73(5):684-690.
84. Wallace DC, Fan W. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev. 2009;23(15):1714-1736.
85. MacGregor GR, Fan WW, Waymire KG, Wallace DC. Generating animal models of human mitochondrial genetic disease using mouse ES cells. In: Notarianni E, Evans MJ, eds. Embryonic Stem Cells. New York, New York, USA: Oxford University Press; 2006:72-104.
86. Marchington DR, Barlow D, Poulton J. Transmitochondrial mice carrying resistance to chloramphenicol on mitochondrial DNA: Developing the first mouse model of mitochondrial DNA disease. Nat Med. 1999;5(8):957-960.
87. Sligh JE, et al. Maternal germ-line transmission of mutant mtDNAs from embryonic stem cellderived chimeric mice. Proc Natl Acad Sci U S A. 2000;97(26):14461-14466.
88. Stewart JB, et al. Strong purifying selection in transmission of mammalian mitochondrial DNA. PLoS Biol. 2008;6(1):e10.
89. Malfatti E, et al. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain. 2007;130(pt 7):1894-1904.
90. Lin CS, et al. A mouse mtDNA mutant model of Leber's Hereditary Optic Neuropathy. Proc Natl Acad Sci U S A. 2012;109(49):20065-20070.
91. Inoue K, et al. Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet. 2000;26(2):176-181.
92. Nakada K, et al. Mitochondria-related male infertility. Proc Natl Acad Sci U S A. 2006;103(41):15148-15153.
93. Sharpley MS, et al. Heteroplasmy of mouse mtDNA is genetically unstable and results in altered behavior and cognition. Cell. 2012;151(2):333-343.
94. Jenuth JP, Peterson AC, Shoubridge EA. Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nat Genet. 1997;16(1):93-95.
95. Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12(10):685-698.
96. van Holst Pellekaan SM, Ingman M, Roberts-Thomson J, Harding RM. Mitochondrial genomics identifies major haplogroups in Aboriginal Australians. Am J Phys Anthropol. 2006;131(2):282-294.
97. Hudjashov G, et al. Revealing the prehistoric settlement of Australia by Y chromosome and mtDNA analysis. Proc Natl Acad Sci U S A. 2007; 104(21):8726-8730.